Exploring Stephen Harrison Md

If you are looking for information about Stephen Harrison Md, you have come to the right place.

  • Good afternoon i'm
  • Presented by
  • "Membrane dynamics and virus entry—From atomic structures to single-molecule movies" from the 2014 5th CSHA Symposium: ...
  • NGM282, a novel variant of FGF19, significantly reduces hepatic steatosis and key biomarkers of NASH.
  • Prof.

In-Depth Information on Stephen Harrison Md

Source: https://www.spreaker.com/user/ehealthradio/ A Liver Biopsy is a test your Stephen A. Harrison, M.D., on the most promising aspects of NGM282 More on this story: https://xtalks.com/how-is-

Dr. Stephen Harrison on 'Mottes to Manors'

We hope this detailed breakdown of Stephen Harrison Md was helpful.

Recent Articles

Dr. Stephen Harrison Discusses Clinical Importance of FibroScan Technology

Dr. Stephen Harrison Discusses Clinical Importance of FibroScan Technology

Source: https://www.spreaker.com/user/ehealthradio/

June 14, 2026
What to expect from a Liver Biopsy by Dr. Stephen Harrison

What to expect from a Liver Biopsy by Dr. Stephen Harrison

A Liver Biopsy is a test your

June 14, 2026
Stephen A. Harrison, M.D., on the most promising aspects of NGM282

Stephen A. Harrison, M.D., on the most promising aspects of NGM282

Stephen A. Harrison, M.D., on the most promising aspects of NGM282

June 14, 2026
How Is Dr. Stephen Harrison’s Legacy Continuing to Accelerate MASH Clinical Research?

How Is Dr. Stephen Harrison’s Legacy Continuing to Accelerate MASH Clinical Research?

More on this story: https://xtalks.com/how-is-

June 14, 2026
Dr. Stephen Harrison COVID-19 Update | Fulton, Illinois

Dr. Stephen Harrison COVID-19 Update | Fulton, Illinois

Good afternoon i'm

June 14, 2026
Webinar: EASL Update - FibroScan Applications in NAFLD-NASH

Webinar: EASL Update - FibroScan Applications in NAFLD-NASH

Presented by

June 14, 2026
CSHL Keynote; Dr Stephen Harrison,Harvard Medical School

CSHL Keynote; Dr Stephen Harrison,Harvard Medical School

"Membrane dynamics and virus entry—From atomic structures to single-molecule movies" from the 2014 5th CSHA Symposium: ...

June 14, 2026
Stephen A. Harrison, M.D., presents Phase 2 NGM282 data at the 2017 International Liver Congress

Stephen A. Harrison, M.D., presents Phase 2 NGM282 data at the 2017 International Liver Congress

NGM282, a novel variant of FGF19, significantly reduces hepatic steatosis and key biomarkers of NASH.

June 14, 2026
NASH management in 2022 | Prof. Stephen Harrison

NASH management in 2022 | Prof. Stephen Harrison

Prof.

June 14, 2026
Dr. Stephen Harrison on 'Mottes to Manors'

Dr. Stephen Harrison on 'Mottes to Manors'

Dr. Stephen Harrison on 'Mottes to Manors'

June 14, 2026
Webinar: EVOLVING DIAGNOSTIC STRATEGIES FOR NAFLD/NASH

Webinar: EVOLVING DIAGNOSTIC STRATEGIES FOR NAFLD/NASH

During the webinar,

June 14, 2026
Becoming Practice-Ready for Imminent NASH Drug Approvals

Becoming Practice-Ready for Imminent NASH Drug Approvals

Listen to expert panel Dr.

June 14, 2026
S5 E14.2 - Remembering Stephen Harrison: Professional Accomplishments

S5 E14.2 - Remembering Stephen Harrison: Professional Accomplishments

Manal Abdelmalek and Naim Alkhouri join co-hosts Jörn Schattenberg, Louise Campbell and Roger Green to reflect on the ...

June 14, 2026